X-Cor Therapeutics
Founded Year
2017Stage
Seed VC | AliveTotal Raised
$2.8MLast Raised
$2.6M | 2 yrs agoMissing: X-Cor Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: X-Cor Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing X-Cor Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
X-Cor Therapeutics is included in 2 Expert Collections, including Medical Devices.
Medical Devices
8,603 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,901 items
Latest X-Cor Therapeutics News
Nov 12, 2020
X-COR Therapeutics , an Allston, MA-based developer of a novel extracorporeal carbon dioxide removal device, closed a $2.6M seed financing. Alira Health’s investment arm, Alira Health Ventures, led the financing with syndication from Good Growth Capital, PiSA Biopharm, Flybridge Partners’ Graduate Syndicate, and other notable angel investors. The company intends to use the funds to continue developing its device toward clinical trials. Led by Jayon Wang, CEO, X-COR is a medical device company creating a carbon dioxide removal device that uses ultra-low-blood flows for the treatment for acute respiratory failure. Its novel technology is a patent-pending medical device and accompanying control algorithm that enables physicians to directly remove excess carbon dioxide from lung failure patients. FinSMEs
X-Cor Therapeutics Frequently Asked Questions (FAQ)
When was X-Cor Therapeutics founded?
X-Cor Therapeutics was founded in 2017.
Where is X-Cor Therapeutics's headquarters?
X-Cor Therapeutics's headquarters is located at 127 Western Ave, Boston.
What is X-Cor Therapeutics's latest funding round?
X-Cor Therapeutics's latest funding round is Seed VC.
How much did X-Cor Therapeutics raise?
X-Cor Therapeutics raised a total of $2.8M.
Who are the investors of X-Cor Therapeutics?
Investors of X-Cor Therapeutics include The Graduate Syndicate, Good Growth Capital, Alira Health Ventures, PiSa Biopharm, Ignite Medtech and 4 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.